Mumbai: Lawyer's father seeks death for killer
Plea seeks enhancement of life imprisonment to death sentence
Source: freepressjournal.in
Avik Sengupta News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Avik Sengupta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Avik Sengupta Today - Breaking & Trending Today
FDA Approves Acute Respiratory Distress Syndrome Trial
Direct Biologics announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, | FDA Approves Acute Respiratory Distress Syndrome Trial
Source: eturbonews.com
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
AUSTIN, Texas, April 26, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that
Source: finanznachrichten.de
FDA approves Direct Biologics to proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
Austin (Texas) [US], April 22 (ANI/PRNewswire): Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19
Source: webindia123.com
Business News | FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
Get latest articles and stories on Business at LatestLY. Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct Biologics is the first and only EV company to receive FDA Phase 3 approval for an Investigational New Drug (IND) indication to date. Business News | FDA Approves Direct Biologics to Proceed with a Landm...
Source: latestly.com